BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$140M |
| 2 |
iShares US Financials ETF
IYF
|
+$119M |
| 3 |
AGN
Allergan plc
AGN
|
+$100M |
| 4 |
Charter Communications
CHTR
|
+$95.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$82.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$909M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.85% |
| 2 | Financials | 5.5% |
| 3 | Healthcare | 5.05% |
| 4 | Consumer Discretionary | 4.67% |
| 5 | Industrials | 3.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
SPS Commerce
SPSC
$2.86B
| $1.02M | ﹤0.01% |
18,367
+12,781
| +229% | +$680K |
|
|
JBTM
1927
JBT Marel
JBTM
$6.23B
| $1.02M | ﹤0.01% |
9,033
+3,316
| +58% | +$355K |
|
1928
Healthcare Realty
HR
$6.6B
| $1.01M | ﹤0.01% |
33,472
-46,868
| -58% | -$1.4M |
|
1929
Exponent
EXPO
$3.19B
| $1.01M | ﹤0.01% |
14,657
+5,194
| +55% | +$343K |
|
1930
Moog Inc Class A
MOG.A
$14B
| $1.01M | ﹤0.01% |
11,833
+4,346
| +58% | +$372K |
|
|
ENV
1931
DELISTED
ENVESTNET, INC.
ENV
| $1.01M | ﹤0.01% |
14,499
-2,307
| -14% | -$150K |
|
1932
Teradata
TDC
$2.57B
| $1.01M | ﹤0.01% |
37,710
-1,843
| -5% | -$51.2K |
|
1933
Federated Hermes
FHI
$4.79B
| $1.01M | ﹤0.01% |
30,926
+2,402
| +8% | +$78.4K |
|
1934
PUT
Public Storage
PSA
$60.9B
| $1M | ﹤0.01% |
47
| – | – |
|
1935
CVR Energy
CVI
$3.54B
| $999K | ﹤0.01% |
24,720
-7,130
| -22% | -$313K |
|
|
FIT
1936
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $999K | ﹤0.01% |
152,020
-92,651
| -38% | -$544K |
|
1937
Pebblebrook Hotel Trust
PEB
$2.06B
| $985K | ﹤0.01% |
36,723
-6,299
| -15% | -$166K |
|
1938
Cullen/Frost Bankers
CFR
$10.6B
| $982K | ﹤0.01% |
10,038
-3,675
| -27% | -$341K |
|
|
ALTR
1939
DELISTED
Altair Engineering Inc
ALTR
| $980K | ﹤0.01% |
27,296
+6,900
| +34% | +$233K |
|
1940
PUT
Teva Pharmaceuticals
TEVA
$42.8B
| $980K | ﹤0.01% |
1,000
-500
| -33% | -$4.46K |
|
|
UNIT
1941
Uniti Group
UNIT
$2.43B
| $980K | ﹤0.01% |
119,347
+65,525
| +122% | +$474K |
|
|
CZZ
1942
DELISTED
Cosan Limited
CZZ
| $977K | ﹤0.01% |
42,765
+97
| +0.2% | +$1.72K |
|
1943
Watts Water Technologies
WTS
$12.8B
| $976K | ﹤0.01% |
9,788
+4,323
| +79% | +$410K |
|
1944
PUT
Liberty Latin America Class C
LILAK
$1.66B
| $973K | ﹤0.01% |
+584
| New | +$9.04K |
|
|
HTO
1945
H2O America
HTO
$2.67B
| $972K | ﹤0.01% |
13,684
+6,051
| +79% | +$428K |
|
1946
PUT
Corning
GLW
$143B
| $972K | ﹤0.01% |
334
-330
| -50% | -$9.58K |
|
1947
Strategic Education
STRA
$1.86B
| $972K | ﹤0.01% |
6,118
+2,179
| +55% | +$303K |
|
1948
ABM Industries
ABM
$2.82B
| $971K | ﹤0.01% |
25,753
+13,585
| +112% | +$507K |
|
|
ENLC
1949
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $970K | ﹤0.01% |
158,319
-31,285
| -17% | -$190K |
|
|
AUY
1950
DELISTED
Yamana Gold, Inc.
AUY
| $970K | ﹤0.01% |
245,451
-143,268
| -37% | -$503K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2019 Portfolio in Review
As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.9% of assets, down from 8.4% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.
- BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
- BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
- BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
- BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
- BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.